HEATHER PRUSIK: Open Payments
NPI 1336419829 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 42 payments from 10 companies in 2025. Trend: 2023 $488 · 2024 $595 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $413 |
| Novo Nordisk Inc | 5 | $202 |
| Lilly USA, LLC | 5 | $95 |
| PFIZER INC. | 4 | $93 |
| Astellas Pharma US Inc | 2 | $63 |
| Gilead Sciences, Inc. | 2 | $45 |
| Exact Sciences Corporation | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: QULIPTA, Wegovy, VRAYLAR, NURTEC ODT, MOUNJARO, Veozah, Ozempic, JARDIANCE.
Industry payments across GA — which companies pay providers there.
